Cargando…
Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities
Breast cancer (BC) is the second leading cause of cancer-related death in American women and more than 90% of BC-related death is caused by metastatic BC (MBC). This review stresses the limited success of traditional therapies as well as the use of nanomedicine for treating MBC. Understanding the bi...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027372/ https://www.ncbi.nlm.nih.gov/pubmed/29794968 http://dx.doi.org/10.3390/nano8060361 |
_version_ | 1783336596537344000 |
---|---|
author | Li, Yunfei Humphries, Brock Yang, Chengfeng Wang, Zhishan |
author_facet | Li, Yunfei Humphries, Brock Yang, Chengfeng Wang, Zhishan |
author_sort | Li, Yunfei |
collection | PubMed |
description | Breast cancer (BC) is the second leading cause of cancer-related death in American women and more than 90% of BC-related death is caused by metastatic BC (MBC). This review stresses the limited success of traditional therapies as well as the use of nanomedicine for treating MBC. Understanding the biological barriers of MBC that nanoparticle in vivo trafficking must overcome could provide valuable new insights for translating nanomedicine from the bench side to the bedside. A view about nanomedicine applied in BC therapy has been summarized with their present status, which is gaining attention in the clinically-applied landscape. The progressions of drug/gene delivery systems, especially the status of their preclinical or clinical trials, are also discussed. Here we highlight that the treatment of metastasis, in addition to the extensively described inhibition of primary tumor growth, is an indispensable requirement for nanomedicine. Along with more innovations in material chemistry and more progressions in biology, nanomedicine will constantly supply more exciting new approaches for targeted drug/gene delivery against MBC. |
format | Online Article Text |
id | pubmed-6027372 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-60273722018-07-13 Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities Li, Yunfei Humphries, Brock Yang, Chengfeng Wang, Zhishan Nanomaterials (Basel) Review Breast cancer (BC) is the second leading cause of cancer-related death in American women and more than 90% of BC-related death is caused by metastatic BC (MBC). This review stresses the limited success of traditional therapies as well as the use of nanomedicine for treating MBC. Understanding the biological barriers of MBC that nanoparticle in vivo trafficking must overcome could provide valuable new insights for translating nanomedicine from the bench side to the bedside. A view about nanomedicine applied in BC therapy has been summarized with their present status, which is gaining attention in the clinically-applied landscape. The progressions of drug/gene delivery systems, especially the status of their preclinical or clinical trials, are also discussed. Here we highlight that the treatment of metastasis, in addition to the extensively described inhibition of primary tumor growth, is an indispensable requirement for nanomedicine. Along with more innovations in material chemistry and more progressions in biology, nanomedicine will constantly supply more exciting new approaches for targeted drug/gene delivery against MBC. MDPI 2018-05-24 /pmc/articles/PMC6027372/ /pubmed/29794968 http://dx.doi.org/10.3390/nano8060361 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Li, Yunfei Humphries, Brock Yang, Chengfeng Wang, Zhishan Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities |
title | Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities |
title_full | Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities |
title_fullStr | Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities |
title_full_unstemmed | Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities |
title_short | Nanoparticle-Mediated Therapeutic Agent Delivery for Treating Metastatic Breast Cancer—Challenges and Opportunities |
title_sort | nanoparticle-mediated therapeutic agent delivery for treating metastatic breast cancer—challenges and opportunities |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027372/ https://www.ncbi.nlm.nih.gov/pubmed/29794968 http://dx.doi.org/10.3390/nano8060361 |
work_keys_str_mv | AT liyunfei nanoparticlemediatedtherapeuticagentdeliveryfortreatingmetastaticbreastcancerchallengesandopportunities AT humphriesbrock nanoparticlemediatedtherapeuticagentdeliveryfortreatingmetastaticbreastcancerchallengesandopportunities AT yangchengfeng nanoparticlemediatedtherapeuticagentdeliveryfortreatingmetastaticbreastcancerchallengesandopportunities AT wangzhishan nanoparticlemediatedtherapeuticagentdeliveryfortreatingmetastaticbreastcancerchallengesandopportunities |